Home / Recalls / First Pharma Associates LLC dba Riverpoint Pharmacy / D-1470-2019

D-1470-2019 Class II Terminated

Recalled by First Pharma Associates LLC dba Riverpoint Pharmacy — Spokane, WA

Recall Details

Product Type
Drugs
Report Date
July 17, 2019
Initiation Date
June 26, 2019
Termination Date
June 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 18 mL b) 12mL

Product Description

Testosterone Cypionate 200 mg/mL Sesame Oil Injection, packaged in a) 9 mL, b) 12 mL vials, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343- 6252

Reason for Recall

Lack of Assurance of Sterility.

Distribution Pattern

ID, WA only

Code Information

Lot #: a) 05022019@31, Exp. 08/4/2019; 05152019@18, Exp. 08/13/2019; b) 05292019@4, Exp. 08/28/2019.

Other recalls by First Pharma Associates LLC dba Riverpoint Pharmacy

  • D-1484-2019 Class II — Glutathione 100 mg/mL Inhalation Solution (PF), 45 mL vial, Rx only, First Phar (June 26, 2019)
  • D-1468-2019 Class II — Testosterone Cypionate 100 mg/mL Sesame Oil Injection, 12mL vial, Rx only, Firs (June 26, 2019)
  • D-1471-2019 Class II — Testosterone Cypionate 200 mg/mL Ethyl Oleate Injection, packaged in a) 7.2 mL. (June 26, 2019)
  • D-1479-2019 Class II — PAP/PHEN/PGE1 22 mg/0.8mg/8mcg/mL Injection, 5mL vial, Rx only, First Pharma Ass (June 26, 2019)
  • D-1481-2019 Class II — PAP/PHEN/PGE1 30 mg/0.83mg/10mcg/mL Injection, 5 mL, Rx only, First Pharma Assoc (June 26, 2019)
  • D-1473-2019 Class II — Testosterone Cyp/Estradiol Cyp 50 mg/2.5 mg/mL Injection, 3mL vial, Rx only, Fir (June 26, 2019)
  • D-1475-2019 Class II — Prostaglandin 20 mcg/mL/Procaine 0.1% Injection, packaged in a) 2.5mL and b)10 m (June 26, 2019)
  • D-1472-2019 Class II — Testosterone Cypionate 100 mg/mLOil Injection Injection, 12 mL vial, Rx only, F (June 26, 2019)
  • D-1480-2019 Class II — PAP/PHEN/PGE1 30 mg/2mg/20mcg/mL Injection, 10mL vial, Rx only, First Pharma As (June 26, 2019)
  • D-1482-2019 Class II — PAP/PHEN/PGE1 18 mg/0.6mg/5.88mcg/mL Injection, 5 mL vial, Rx only, First Pharma (June 26, 2019)